News Briefs

Cimeio Therapeutics fetches $50m Series A

Cimeio Therapeutics, a cell therapy company, has raised $50 million in Series A funding.

14 April 2022

Cimeio Therapeutics, a cell therapy company, has raised $50 million in Series A funding. The backer was Versant Ventures.

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Register now